Beximco submits Remdesivir sample to DGDA before Eskayef
The drug has grabbed attention as one of the most promising treatments for Covid-19 Beximco Pharmaceuticals has said it has submitted final product samples of its Remdesivir to the drug administration on May 7. In a statement sent to the media on Saturday, the drug manufa...